{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:09:24Z","timestamp":1759176564402},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,3,7]],"date-time":"2008-03-07T00:00:00Z","timestamp":1204848000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s00403-008-0841-6","type":"journal-article","created":{"date-parts":[[2008,3,6]],"date-time":"2008-03-06T10:03:55Z","timestamp":1204797835000},"page":"297-301","source":"Crossref","is-referenced-by-count":21,"title":["Interferon-\u03b2 therapy for malignant melanoma: the dose is crucial for inhibition of proliferation and induction of apoptosis of melanoma cells"],"prefix":"10.1007","volume":"300","author":[{"given":"Hitomi","family":"Kubo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Ashida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Kageshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Saida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,7]]},"reference":[{"key":"841_CR1","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0002-9440(10)65007-9","volume":"156","author":"A Albini","year":"2000","unstructured":"Albini A, Marchisone C, Del Grosso F, Benelli R, Masiello L, Tacchetti C et al (2000) Inhibition of angiogenesis and vascular tumor growth by interferon producing cells: A gene therapy approach. Am J Pathol 156:1381\u20131393","journal-title":"Am J Pathol"},{"key":"841_CR2","first-page":"423","volume":"139","author":"HR Byers","year":"1991","unstructured":"Byers HR, Etoh T, Doherty RJ, Sober JA, Mihm CM Jr (1991) Cell migration and actin organization in cultured human primary, reccurent cutaneous and metastatic melanoma. Am J Pathol 139:423\u2013435","journal-title":"Am J Pathol"},{"key":"841_CR3","first-page":"1821","volume":"7","author":"M Chawla-Sarkar","year":"2001","unstructured":"Chawla-Sarkar M, Leaman DW, Borden EC (2001) Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2. Clin Cancer Res 7:1821\u20131831","journal-title":"Clin Cancer Res"},{"key":"841_CR4","doi-asserted-by":"crossref","first-page":"847","DOI":"10.4049\/jimmunol.169.2.847","volume":"169","author":"M Chawla-Sarkar","year":"2002","unstructured":"Chawla-Sarkar M, Leaman DW, Jacobs BS, Borden EC (2002) IFN-beta pretreatment sensitizes human melanoma cells to TRAIL\/Apo2 ligand-indeced apoptosis. J Immunol 169:847\u2013855","journal-title":"J Immunol"},{"key":"841_CR5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1101\/gad.9.1.15","volume":"9","author":"LP Deiss","year":"1995","unstructured":"Deiss LP, Feinstein E, Berissi H, Cohen O, Kimchi A (1995) Identification of a novel serine\/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. Genes Dev 9:15\u201330","journal-title":"Genes Dev"},{"key":"841_CR6","first-page":"872","volume":"59","author":"Z Dong","year":"1999","unstructured":"Dong Z, Greene G, Pettaway C, Dinney CP, Eue I, Lu W et al (1999) Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta. Cancer Res 59:872\u2013879","journal-title":"Cancer Res"},{"key":"841_CR7","doi-asserted-by":"crossref","first-page":"231s","DOI":"10.1111\/1523-1747.ep12875837","volume":"95","author":"C Garbe","year":"1990","unstructured":"Garbe C, Krasagakis K, Zouboulis CC, Schroder K, Kruger S, Stadler R et al (1990) Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype. J Invest Dermatol 95:231s\u2013237s","journal-title":"J Invest Dermatol"},{"key":"841_CR8","first-page":"291","volume":"3","author":"C Garbe","year":"1993","unstructured":"Garbe C (1993) Chomotherapy and chemoimmunotherapy in disseminated malignant melanoma. Melanoma Res 3:291\u2013299","journal-title":"Melanoma Res"},{"key":"841_CR9","first-page":"3354","volume":"6","author":"YK Hong","year":"2000","unstructured":"Hong YK, Chung DS, Joe YA, Yang YJ, Kim KM, Park YS et al (2000) Efficient inhibition in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development. Clin Cancer Res 6:3354\u20133360","journal-title":"Clin Cancer Res"},{"key":"841_CR10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1346-8138.1995.tb03889.x","volume":"22","author":"T Horikoshi","year":"1995","unstructured":"Horikoshi T, Fukuzawa K, Hanada N, Ezoe K, Eguchi H, Hamaoka S et al (1995) In vitro comparative study of the antitumor effects of human interferon-alpha, beta, and gamma on the growth and invasive potential of human melanoma cells. J Dermatol 22:631\u2013636","journal-title":"J Dermatol"},{"issue":"15","key":"841_CR11","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/jnci\/84.15.1185","volume":"84","author":"TG Johns","year":"1992","unstructured":"Johns TG, Mackay IR, Callister KA, Hertzog PJ, Devenish RJ, Linnane AW (1992) Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon \u03b2. J Natl Cancer Inst 84(15):1185\u20131190","journal-title":"J Natl Cancer Inst"},{"key":"841_CR12","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1006\/bbrc.1996.0303","volume":"219","author":"K Kikuchi","year":"1996","unstructured":"Kikuchi K, Nakagawa H, Kondo T, Etoh T, Byers HR, Mihm CM Jr et al (1996) Decreased ETB receptor expression in human metastatic melanoma cells. Biochem Biophys Res Commun 219:734\u2013739","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"841_CR13","first-page":"791","volume":"16","author":"I Kopf","year":"1996","unstructured":"Kopf I, Hanson C, Delle U, Weimarck A, Stierner U (1996) Action of interferon alpha and beta on four human melanoma cell lines in vitro. Anticancer Res 16(2):791\u2013798","journal-title":"Anticancer Res"},{"key":"841_CR14","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/sj.jid.5700381","volume":"126","author":"T Liu","year":"2006","unstructured":"Liu T, Biddle D, Hanks AN, Brouha B, Yan H, Lee RM et al (2006) Activation of dual apoptotic pathways in human melanocytes and protection by Survivin. J Invest Dermatol 126:2247\u20132256","journal-title":"J Invest Dermatol"},{"key":"841_CR15","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2340\/0001555575494","volume":"75","author":"T Nagatani","year":"1995","unstructured":"Nagatani T, Ichiyama S, Onuma R, Miyazawa M, Matsuzaki T, Miyagawa K et al (1995) The use of DAV (DTIC, ACNU and VCR) and natural interferon-beta combination therapy in malignant melanoma. Acta Derm Venerol 75:494","journal-title":"Acta Derm Venerol"},{"key":"841_CR16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/jir.1997.17.355","volume":"17","author":"X Q Qin","year":"1997","unstructured":"Qin X Q, Runkel L, Deck C, DeDios C, Barsoum J (1997) Interferon-beta induces S phase accumulation selectively in human transformed cells. J Interferon Cytokine Res 17:355\u2013367","journal-title":"J Interferon Cytokine Res"},{"key":"841_CR17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","volume":"67","author":"GR Stark","year":"1998","unstructured":"Stark GR, Kerr IM, Williams BRG, Silverman RH, Schreiber RD (1998) How cells respond to interferons. Annu Rev Biochem 67:227\u2013264","journal-title":"Annu Rev Biochem"},{"key":"841_CR18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00008390-199306000-00005","volume":"3","author":"U Stamm von","year":"1993","unstructured":"von Stamm U, Brocker EB, von Depka Prondzinski M, Ruiter DJ, Rumke P, Broding C et al (1993) Effects of systemic interferon-alpha(IFN-alpha) on the antigenic phenotype of melanoma metastases. EORTC Melanoma Group Cooperative Study No. 18852. Melanoma Res 3:173\u2013180","journal-title":"Melanoma Res"},{"key":"841_CR19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/excr.1998.4329","volume":"247","author":"H Zhang","year":"1999","unstructured":"Zhang H, Koty PP, Mayotte J, Levitt ML (1999) Induction of multiple programmed cell death pathways by IFN-beta in human non-small-cell lung cancer cell lines. Exp Cell Res 247:133\u2013141","journal-title":"Exp Cell Res"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-008-0841-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-008-0841-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-008-0841-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T07:04:18Z","timestamp":1708671858000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-008-0841-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,7]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["841"],"URL":"https:\/\/doi.org\/10.1007\/s00403-008-0841-6","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,7]]}}}